Analyst Ratings for Immuneering Corporation (IMRX)
IMRX Rating Summary
IMRX Price Target Summary
- Highest: $30.00 (Oppenheimer)
- Lowest: $3.50 (Jefferies)
- Average: $14.30
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$14.30 (+168.3%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 64%
Avg. $ Target:
$14.30 (+168.3%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 64%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/31/2025 | Leerink Partners | Andrew Berens | New Coverage | Outperform (N/A) |
15.00 (N/A) |
6.41 (5.33) |
-16.85% | Details |
| 12/13/2024 | Morgan Stanley | Jeffrey Hung | Downgrade | Underweight (Equalweight) |
N/A (N/A) |
2.14 (5.33) |
149.07% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
